Dr. Marco Falasca

• 
  www.currentbiodata.com/virtual_faculties/marco_falasca_ - [Cached Version]
  Published on: 11/4/2007    Last Visited: 11/4/2007  

  Dr Marco Falasca
  
  Editorial Board Member, Lipid Signaling Virtual Academy
  
  Marco Falasca is Principal Research Fellow at the Department of Medicine, University College London.He was Head of the Physiopathology of Cell Signalling unit at the Consorzio Mario Negri Sud, Italy where he also obtained his Ph.D. During his Postdoctoral years in Joseph Schlessinger's laboratory at the New York University Medical Center, he researched intracellular signals mediated by the lipid products of PI3K.In particular his work highlighted the crucial role of PI3K in regulation of the enzyme phospholipase Cgamma1 (PLCg1).Falasca serves on Editorial Boards of the International Archives of Biosciences and Gene Therapy & Molecular Biology.

• 
  www.ucl.ac.uk/news/news-articles/0701/07012401 - [Cached Version]
  Published on: 1/24/2007    Last Visited: 3/3/2007  

  UCL Views: Dr Marco Falasca

• 
  www.moakes.com/vegan-health.htm - [Cached Version]
  Published on: 4/29/2007    Last Visited: 4/29/2007  

  Dr Marco Falasca of University College London (UCL) is quoted as saying that "our study suggests the importance of a diet enriched in foods such as beans, nuts and cereals, which could help prevent cancer".

• 
  www.wcrf.org/research/regular_grant_programme/funded_re - [Cached Version]
  Last Visited: 9/8/2009  

  Marco Falasca, PhD University College London

• 
  www.ucl.ac.uk/news/ucl-views/marcofalasca - [Cached Version]
  Published on: 3/3/2007    Last Visited: 3/3/2007  

  This image is of Dr Marco Falasca (UCL Medicine)
 who will lecture on 17 October 2006 as part of the 2006 Lunch Hour Lecture series, designed to give members of the public, staff and students an insight into UCL's outstanding research and how it impacts on the world today.
  
  Delivered by UCL's leading academics, the lectures offer a lively and accessible introduction to a broad range of disciplines, from art to zoology and beyond.Dr Falasca will talk on ‘Uncoding the SOS of Cells to Find Cures'.
  
  He explains: "Medical researchers are codecrackers in disguise.

• 
  chris.berrie.com/cbcvscires.htm - [Cached Version]
  Last Visited: 7/4/2009  

  Marco Falasca
  
  Department of Medicine, UniversityCollege of London, London, UK

• 
  Anti-cancer compound found in beans, nuts, cereals - [Cached Version]
  Last Visited: 9/15/2005  

  'Our study suggests the importance of a diet enriched in foods such as beans, nuts and cereals which could help prevent cancer,' said Dr Marco Falasca, of UCL,s Sackler Institute, who reported the finding in the journal Cancer Research.
  
  He and his team discovered that the compound inhibits an enzyme called phosphoinositde 3-kinase which promotes tumour growth.
  
  Scientists have been trying to develop drugs to inhibit the cancer-promoting enzyme but have had difficulty so far.
  
  When the researchers tested inositol pentakisphosphate in mice and cancer cells in the laboratory, it killed the animal tumours and enhanced the effect of drugs used against ovarian and lung cancer cells.
  
  'Our work will now focus on establishing whether the phosphate inhibitor can be developed into an anti-cancer agent for human therapy,' Falasca said in a statement.

• 
  Cancer :: Anti-Cancer Compound Found in Beans, Nuts,... - [Cached Version]
  Published on: 10/28/2004    Last Visited: 11/22/2005  

  Dr Marco Falasca of University College London (UCL), and team, tested inositol pentakisphosphate (a natural substance found in beans, peas, nuts and cereals) on mice and cancer cells in the lab.

• 
  Division of Mediine - [Cached Version]
  Published on: 1/6/2007    Last Visited: 1/6/2007  

  Dr Marco Falasca

• 
  Dr. Pressman - News Item - [Cached Version]
  Published on: 9/1/2005    Last Visited: 12/23/2008  

  Dr Marco Falasca of University College London (UCL), and team, tested inositol pentakisphosphate (a natural substance found in beans, peas, nuts and cereals) on mice and cancer cells in the lab.

Page:  1 2